Clinical Trial

Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery

Study acronym: PrevProgAKI
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury. To investigate whether an implementation of a supportive extended care "bundle" in high-risk patients for persistent acute kidney injury (AKI) can reduce the occurrence of persistent surgical AKI. In order to investigate whether the extended KDIGO bundle can prevent persistent AKI in patients with high chemokine ligand 14 (CCL14) as well as in patients with low CCL14, patients will be randomized with stratification by the CCL-value.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05275218
Lead Sponsor University Hospital Muenster
Collaborators: Baxter Healthcare Corporation
Conditions Acute Kidney Injury (Nontraumatic)
Enrollment 480 participants
Start Date 2023-03-22
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-01